Verified Nov 2026
Other
·

Barcelona, Catalonia
·
Since 1949
Lacer is a Spanish pharmaceutical laboratory founded in 1949 and headquartered in Barcelona, with 500–1,000 employees and estimated revenue of $100–250M. Acquired by Italfarmaco in July 2022, the company manufactures oral health, hair care, skin care, and pharmaceutical products for cardiovascular, urology, musculoskeletal, and gynecology applications. It serves pharmacy channels across 18 countries with brands including Thrombocid, Pilexil, and Talquistina.
Lacer at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
1949
Headquarters
Barcelona, Catalonia
Industries
Automotive
Medical
Industrial Equipment
Overview
Lacer is a Spanish pharmaceutical laboratory founded in 1949 and headquartered in Barcelona, with 500–1,000 employees and estimated revenue of $100–250M. Acquired by Italfarmaco in July 2022, the company manufactures oral health, hair care, skin care, and pharmaceutical products for cardiovascular, urology, musculoskeletal, and gynecology applications. It serves pharmacy channels across 18 countries with brands including Thrombocid, Pilexil, and Talquistina.
At a glance
Attribute | Detail |
|---|---|
Founded | 1949 |
Headquarters | Barcelona, Catalonia |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
What Lacer makes
The company manufactures a broad portfolio spanning oral hygiene, hair loss treatments, varicose vein therapies, and cardiovascular and gynecological pharmaceuticals distributed through pharmacy channels.
Latest developments
2026-11-12 — Lote 2 — CEMOSA - LACER INGENIERIA, S.L. · Adjudera (adjudera.com)
2026-07-06 — 🚀 El equipo de Lacer sigue creciendo. | Lacer (linkedin.com)
2026-06-25 — 🚀 Seguimos sumando talento a nuestros equipos. | Lacer (linkedin.com)
2026-04-23 — El crecimiento de Lacer se construye sumando talento y nuevas capacidades al equipo. | Lacer (linkedin.com)
2026-04-07 — Seguimos sumando talento en Lacer con la incorporación de nuevos perfiles en áreas clave de la compañía. | Lacer (linkedin.com)
2026-03-12 — LACER refuerza su liderazgo en salud en INFARMA 2026 (infarma.es)
Company details
Lacer holds a position in the pharmacy channel for oral hygiene, varicose veins, and hair loss treatments, operating as part of the Italfarmaco group following its 2022 acquisition. Lacer was founded in 1949, has an estimated 500-1,000 employees, and is headquartered in Barcelona, Catalonia.
Frequently asked questions
What does Lacer do?
Lacer is a Spanish pharmaceutical laboratory founded in 1949 and headquartered in Barcelona, with 500–1,000 employees and estimated revenue of $100–250M. Acquired by Italfarmaco in July 2022, the company manufactures oral health, hair care, skin care, and pharmaceutical products for cardiovascular, urology, musculoskeletal, and gynecology applications. It serves pharmacy channels across 18 countries with brands including Thrombocid, Pilexil, and Talquistina.
Where is Lacer headquartered?
Lacer is headquartered in Barcelona, Catalonia (605 Avinguda Diagonal, Barcelona, Catalonia, 08028).
When was Lacer founded?
Lacer was founded in 1949.
How big is Lacer?
Lacer has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
